Search for: "v. Teva Pharmaceuticals USA, Inc." Results 41 - 60 of 440
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
28 Jan 2015, 10:00 pm by Courtenay C. Brinckerhoff
Watson Pharmaceuticals, Inc., to the Federal Circuit “for further consideration in light of Teva Pharmaceuticals USA, Inc., v. [read post]
14 Jul 2013, 9:23 pm by Patent Docs
• Defendants: Teva Pharmaceuticals USA Inc.; Teva Pharmaceutical Industries Ltd. [read post]
25 Aug 2008, 4:10 am
STMicroelectronics, Inc., Teva Pharmaceuticals USA, Inc. v. [read post]
13 May 2009, 9:50 pm
After Defendant-Appellant Teva Pharmaceuticals USA, Inc. notified P&G of its intent to market a generic version of... [read post]
1 Jul 2014, 10:00 pm by Courtenay C. Brinckerhoff
Teva Pharmaceuticals USA, Inc., the Federal Circuit affirmed the district court’s finding that BMS’s Baraclude® patent is invalid as obvious. [read post]
18 Nov 2015, 10:00 pm by Courtenay C. Brinckerhoff
Teva Pharmaceuticals USA Inc. and Momenta Pharmaceuticals, Inc. v Amphastar Pharmaceuticals, Inc., the Federal Circuit interpreted two important sections of the infringement statute, 35 USC § 271. [read post]
31 Mar 2014, 6:43 am by Andrew Hamm
The Court has granted Teva Pharmaceuticals USA, Inc. v. [read post]
7 Mar 2010, 9:28 pm by Patent Docs
LLC • Defendants: Teva Pharmaceuticals USA, Inc.; Teva Pharmaceutical Industries Ltd. [read post]
9 Jan 2017, 9:36 am by Lawrence B. Ebert
In other words, Copaxone should remain a $4 billion drug, annually.link to Pantagraph: http://www.pantagraph.com/business/investment/markets-and-stocks/factors-that-sent-teva-pharmaceutical-industries-ltd-sliding-in/article_74234eee-a5ec-5c58-a54b-82597151b1e6.htmlPatents covering "three per week" dosing were not at issue in the Supreme Court case of Teva Pharmaceuticals USA, Inc. v. [read post]
18 Aug 2013, 8:54 pm by Patent Docs
Teva Biopharmaceuticals USA, Inc. et al. 2:13-cv-04911; filed August 12, 2013 in the District Court of New Jersey • Plaintiffs: Amgen Inc.; Amgen Manufacturing, Limited • Defendants: Teva Biopharmaceuticals USA, Inc.; Teva Pharmaceuticals USA, Inc.; Teva Pharmaceutical Industries Ltd. [read post]
22 May 2011, 8:41 pm by Patent Docs
• Defendant: Teva Pharmaceuticals USA, Inc. [read post]
25 Jun 2015, 9:48 pm by Patent Docs
Philips Electronics North America), the More They Stay the Same (Teva Pharmaceuticals USA, Inc. v. [read post]
5 Oct 2020, 1:15 pm by Rebecca Tapscott
Teva Pharmaceuticals USA, Inc., the United States Court of Appeals for the Federal Circuit (CAFC) on Friday reversed a district court’s motion for judgment as a matter of law (JMOL) for Teva, finding that Teva was liable for induced infringement of GlaxoSmithKline's (GSK’s) patent directed to a method of treating Congestive Heart Failure (CHF) using carvedilol..... [read post]
24 Apr 2016, 9:02 pm by Patent Docs
Teva Pharmaceuticals USA Inc. et al. v. [read post]
9 Oct 2009, 9:11 am
Teva Pharmaceuticals USA, Inc. and Teva Pharmaceutical Industries Ltd. [read post]
17 Mar 2013, 9:39 pm by Patent Docs
• Defendants: Teva Pharmaceutical Industries, Ltd.; Teva Pharmaceuticals USA, Inc. [read post]
15 May 2011, 8:55 pm by Patent Docs
• Defendant: Teva Pharmaceuticals USA Inc. [read post]
11 Mar 2014, 9:09 pm by Ben Vernia
Teva Pharmaceuticals USA is located in North Wales, Pa., and IVAX LLC is a Florida company [read post]